Psilocybin has been rapidly gaining traction as a safe, fast-acting, and effective treatment for many mood disorders such as anxiety and depression. Now, psilocybin is showing promise for neuroregeneration and motor recovery in methods of treating phantom pain.
Recent studies regarding the biosynthesis of psilocybin provide an answer to this age-old question.
Magic mushrooms have multiple active components including phenethylamine. These molecules are almost never acknowledged and are probably involved the pharmacology of magic mushrooms.
Despite many anecdotal reports of wood lover paralysis, no controlled scientific studies have been conducted. One hypothesis for this mysterious symptom is the presence of "black rot".
Psilocybin and psilocin are two different molecules found in magic mushrooms. Our current understanding is that psilocybin is inactive but rapidly converted into psilocin, which provides the observed activity.
The term "wood lover paralysis" refers to a temporary state of muscle weakness and/or paralysis that begins several hours after consuming certain types of "magic" mushrooms.
Baeocystin is closely chemically related to psilocybin, but the scientific community has very little data on baeocystin or its human pharmacology.
Researchers measured the effects of psilocybin by comparing brain scans.
On June 4, 2018, The Atlantic published Michael Pollan’s account of studying “magic” mushrooms alongside world-famous mycologist Paul Stamets. According to the story, Stamets took Pollan hunting for the Psilocybe...
New research published in the Journal of Psychopharmacology examines the association between lifetime psychedelic use and intimate partner violence.